Ipsum Pharmaceuticals Private Limited

Ipsum Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2012PTC082077 Incorporated 20 July 2012 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2021
₹55.01 Lakh
▼ 28% YoY
Net profit · FY 2021
₹1.12 Lakh
Net margin 2%
EBITDA · FY 2021
₹4.3 Lakh
EBITDA margin 7.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹47 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered

About Ipsum Pharmaceuticals Private Limited

Data last updated:

Ipsum Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 July 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PTC082077. Its GSTIN is 36AADCI1460N1ZF (Telangana).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹47 Lakh. It is led by directors including Palla Aparna and Shyamala Budda.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068.

As per the financials filed for FY 2021, the company reported a revenue of ₹55.01 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.12 Lakh (net margin 2%) and EBITDA of ₹4.3 Lakh (EBITDA margin 7.8%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 13% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232TG2012PTC082077
Registration Number 082077
Incorporation Date 20 July 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Ipsum Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2012PTC082077. The current CIN is U24232TG2012PTC082077, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2012PTC082077Current
U24232AP2012PTC082077Previous

Contact details

Ipsum Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ipsum Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ipsum Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ipsum Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ipsum Pharmaceuticals Private Limited, buy the company report.

Financials of Ipsum Pharmaceuticals Private Limited

FY 2021 filings available

Ipsum Pharmaceuticals Private Limited reported revenue of ₹55.01 Lakh (down 28% YoY) for FY 2021.

Revenue · FY 2021
₹55.01 Lakh ▼ 28%
Net profit · FY 2021
₹1.12 Lakh margin 2%
EBITDA · FY 2021
₹4.3 Lakh margin 7.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 28%
3 years · compounded
▼ 22%
5 years · compounded
▼ 13%
EBITDA CAGR growth
1 year
▼ 53%
3 years · compounded
▼ 21%
5 years · compounded
▼ 11%

Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 28% fall in the latest year. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.3 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.12 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin7.8%
Net Profit Margin2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ipsum Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ipsum Pharmaceuticals Private Limited

Ipsum Pharmaceuticals has 5 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Palla AparnaDirector20 Jul 201214 Years 4 MonthsCurrent
Shyamala BuddaDirector20 Jul 201214 Years 4 MonthsCurrent
Appala ShashikalaDirector20 Jul 201214 Years 4 MonthsCurrent
Abhishek BuddaDirector20 Jul 201214 Years 4 MonthsCurrent
Narender Rao KalakuntlaDirector20 Jul 201214 Years 4 MonthsCurrent

Peer comparison

Ipsum Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Symbiosis Labs Private Limited₹55.09 Lakh (FY 2025)-29.0%New Delhi, Delhi, India
Wilfred Pharmaceuticals Private Limited₹55.07 Lakh (FY 2025)5084.0%Aurangabad, Maharashtra, India
Qristol Healthcare Private Limited₹55.05 Lakh (FY 2023)-53.0%Dehradun, Uttarakhand, India
Ipsum Pharmaceuticals Private Limitedthis company₹55.01 Lakh (FY 2021)₹1.12 Lakh2%-28.0%Hyderabad, Telangana, India
Lift Life Pharmaceuticals Private Limited₹54.96 Lakh (FY 2023)1.0%Chandigarh, India
Synergy Pharmasource Private Limited₹54.89 Lakh (FY 2024)Ahmedabad, Gujarat, India

To see the full peer comparison of Ipsum Pharmaceuticals Private Limited, buy the company report.

Auditor

Ipsum Pharmaceuticals Private Limited is audited by JANGAM & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
JANGAM & ASSOCIATESFY 2017013288S

Shareholding

The shareholding of Ipsum Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ipsum Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ipsum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ipsum Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AADCI1460N1ZFTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Ipsum Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ipsum Pharmaceuticals Private Limited has 5 board changes on record since 2012: 5 appointments. The latest: Abhishek Budda was appointed as Director on 20 Jul 2012.

AGM
Ipsum Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Ipsum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Appointed
Abhishek Budda was appointed as Director.
Appointed
Appala Shashikala was appointed as Director.
Appointed
Narender Rao Kalakuntla was appointed as Director.
Appointed
Palla Aparna was appointed as Director.
Appointed
Shyamala Budda was appointed as Director.
Incorporation
20 Jul 2012
Ipsum Pharmaceuticals Private Limited was registered on 20 Jul 2012 with Roc Hyderabad & aged 14 years 4 months as per MCA records.

Frequently asked questions

Ipsum Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 July 2012 (14+ years old) and is registered under CIN U24232TG2012PTC082077.

Ipsum Pharmaceuticals has 5 current directors:

The latest financial statements of Ipsum Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Ipsum Pharmaceuticals is 36AADCI1460N1ZF, registered in Telangana.

The CIN (Corporate Identification Number) of Ipsum Pharmaceuticals is U24232TG2012PTC082077. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ipsum Pharmaceuticals was incorporated on 20 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Ipsum Pharmaceuticals by revenue are Symbiosis Labs Private Limited, Wilfred Pharmaceuticals Private Limited, Qristol Healthcare Private Limited, Lift Life Pharmaceuticals Private Limited, Synergy Pharmasource Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Abhishek Budda was appointed as Director on 20 Jul 2012. Appala Shashikala was appointed as Director on 20 Jul 2012. Narender Rao Kalakuntla was appointed as Director on 20 Jul 2012. Ipsum Pharmaceuticals has 5 board changes on record in total.

The registered office of Ipsum Pharmaceuticals is at Plot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068.

Ipsum Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Ipsum Pharmaceuticals is compliant as of 14 August 2026. The company is actively filing with the Registrar of Companies.